What causes increased blood pressure (hypertension) in patients with end-stage renal disease (ESRD) undergoing hemodialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Increased Blood Pressure During Hemodialysis

Inadequate achievement of dry weight is the primary cause of increased blood pressure during hemodialysis, with excess fluid remaining in the extracellular compartment despite dialysis sessions. 1

Primary Mechanism: Volume Overload

Failure to reach dry weight is the dominant mechanism driving hypertension in hemodialysis patients. 1 This occurs through several pathways:

  • Insufficient dialysis time: Conventional 3-4 hour sessions may be too short for patients requiring aggressive ultrafiltration, making adequate fluid removal impossible. 1

  • Paradoxical volume expansion: When ultrafiltration is accelerated to compensate for limited time, it can precipitate hypotension requiring saline administration, which further expands extracellular volume beyond the original target. 1

  • Excessive interdialytic sodium and water intake: High sodium intake between sessions (often exceeding the recommended 4.7-5.8g sodium chloride daily) drives fluid accumulation that cannot be adequately removed. 1

The relationship between volume and blood pressure may be sigmoidal rather than linear—blood pressure remains controlled until physiological autoregulation fails, then rises sharply once a threshold is exceeded. 1

Secondary Pathophysiological Mechanisms

Beyond volume overload, multiple pathways contribute to hypertension in dialysis patients:

Vascular and Endothelial Dysfunction

  • Arterial stiffness from arteriosclerosis limits vascular compliance, making blood pressure more sensitive to volume changes. 1
  • Salt-related reduction in nitric oxide formation impairs normal vasodilation. 1

Neurohumoral Activation

  • Sympathetic nervous system overactivity contributes to vasoconstriction and may be particularly important in patients who develop hypertension despite adequate ultrafiltration. 1
  • Renin-angiotensin system activation can occur, especially when excessive ultrafiltration triggers compensatory vasoconstriction. 1

Erythropoietin Therapy

  • Recombinant human erythropoietin (rhEPO) causes blood pressure elevation in 35% of previously hypertensive patients and 44% of normotensive patients. 1
  • Risk is highest in patients with severe anemia, rapid correction of anemia, and pre-existing hypertension. 1
  • The hypertensive effect typically occurs within 2-16 weeks of initiation but can develop months later. 1

Paradoxical Intradialytic Hypertension

A small subset of patients experience blood pressure elevation during fluid removal, a phenomenon that is poorly understood. 1

Proposed mechanisms include:

  • Excessive renin-angiotensin system stimulation precipitated by rapid volume depletion. 1
  • Excessive sympathetic nervous system activation with resulting vasoconstriction. 1
  • Removal of dialyzable antihypertensive medications (enalapril, ramipril, atenolol, acebutolol, nadolol, minoxidil) during the dialysis session. 1

In seven patients studied with this characteristic and marked cardiac dilation, intense ultrafiltration paradoxically reduced blood pressure, suggesting cardiac dysfunction may play a role. 1

Critical Clinical Pitfalls

The "lag phenomenon": Even after achieving dry weight and normalizing extracellular fluid volume within weeks, elevated blood pressure may continue to decrease for 8 months or longer. 2 Clinicians must avoid prematurely escalating antihypertensive medications during this period.

Inadequate dialysis prescription: When conventional dialysis time proves insufficient, attempting to accelerate ultrafiltration creates a vicious cycle—hypotension requires saline administration, preventing achievement of dry weight and perpetuating hypertension. 1 The solution is extending dialysis time or frequency, not faster ultrafiltration. 2, 3

Dialysate sodium concentration: Using dialysate sodium >140 mmol/L impairs sodium removal and contributes to volume expansion. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Intradialytic Hypertension Mechanisms and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

For an adult on chronic hemodialysis presenting with weeks of cough, episodic palpitations, persistent hypertension (~180/90 mm Hg) during dialysis sessions, and anxiety attacks, is sublingual clonidine 75 µg appropriate and what other pharmacologic and non‑pharmacologic management steps should be taken?
In an ESRD patient on regular hemodialysis presenting with a several‑week cough, intermittent palpitations, severe hypertension and anxiety attacks during dialysis, is sublingual clonidine 75 µg appropriate and what alternative pharmacologic and non‑pharmacologic management should be used?
What is the most likely cause of low arterial pressure in a 63-year-old female patient with chronic kidney disease (CKD) secondary to hypertension, undergoing hemodialysis?
What is the appropriate management for a hemodialysis patient with pain in the mastoid to external auditory meatus (EAM) and temporal region of the head?
What are suitable antihypertensive (anti-hypertensive) options for patients undergoing dialysis (renal replacement therapy)?
What are the current guidelines for managing dengue fever with warning signs, such as abdominal pain, persistent vomiting, and rapid decrease in platelet count, in patients presenting with these symptoms?
Can I add dopamine to a patient with severe shock who is already receiving norepinephrine and vasopressin?
What is the normal procalcitonin (PCT) level in an adult patient with sepsis, but not in shock?
What foods should a patient with diverticulitis eat during the acute phase and recovery?
What is the next step in managing a patient with suspected infective endocarditis, pre-diabetes, and currently on broad-spectrum antibiotics, whose blood cultures (blood CS) from 3 different sites showed no growth, and is still awaiting 2D echo results?
What are the indications for Remdesivir (Veklury) in patients with COVID-19, including dosage and patient demographics?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.